Skip to main content
Top
Published in:

18-12-2024 | Penicillins | Original Article

Risk of mortality in Fusobacterium species bloodstream infection from a large Australian cohort

Authors: Adam G. Stewart, Felicity Edwards, Patrick N. A. Harris, David L. Paterson, Kevin B. Laupland

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2025

Login to get access

Abstract

Background

Fusobacterium species are anaerobic Gram-negative bacilli which are uncommon causes of bloodstream infection (BSI). This genus commonly colonises the gastrointestinal tract and can result in significant morbidity.

Methods

All blood cultures with growth of Fusobacterium species among residents of Queensland, Australia (population ≈ 5 million) were retrospectively identified over a 20-year period. Clinical, microbiological and outcome information was obtained from state-wide databases.

Results

377 incident Fusobacterium species BSI among 375 individuals for an age and sex-standardised incidence of 4.4 per million residents per year. Median age was 47 years (IQR, 24.9–65.8) and 156 (42%) incident episodes were in females. There was a bimodal frequency distribution with respect to age with peaks occurring around 20 and 65 years, respectively. The most identified source of infection was the abdominal (17%), followed by head and neck (12%). 8% of patients had a septic thrombus present, and 4% had an abscess associated with their BSI. Most isolates were F. nucleatum (142, 38%) and F. necrophorum (140, 37%). 9% of isolates were resistant to penicillin. Older age (aHR 1.02, 95% CI 1.01–1.05), healthcare-associated hospital onset (aHR 3.16, 95% CI 1.35–7.40), and Charlson Comorbidity index (aHR 1.20, 95% CI 1.06–1.35) were all associated with 30-day all cause case-fatality. Oropharyngeal source appeared to be a protective factor (P = 0.02).

Conclusions

Fusobacterium species BSI results in significant morbidity and can cause death in vulnerable patient groups such as the elderly and those with malignancy. An identifiable oropharyngeal source identifies a favourable host.
Literature
1.
go back to reference Riordan T (2007) Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre’s syndrome. Clin Microbiol Rev 20(4):622–659CrossRefPubMedPubMedCentral Riordan T (2007) Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre’s syndrome. Clin Microbiol Rev 20(4):622–659CrossRefPubMedPubMedCentral
2.
go back to reference Henry S, DeMaria A Jr., McCabe WR (1983) Bacteremia due to Fusobacterium species. Am J Med 75(2):225–231CrossRefPubMed Henry S, DeMaria A Jr., McCabe WR (1983) Bacteremia due to Fusobacterium species. Am J Med 75(2):225–231CrossRefPubMed
3.
go back to reference Citron DM (2002) Update on the taxonomy and clinical aspects of the genus fusobacterium. Clin Infect Dis 35(Suppl 1):S22–S27CrossRefPubMed Citron DM (2002) Update on the taxonomy and clinical aspects of the genus fusobacterium. Clin Infect Dis 35(Suppl 1):S22–S27CrossRefPubMed
4.
go back to reference Jang SS, Hirsh DC (1994) Characterization, distribution, and microbiological associations of Fusobacterium spp. in clinical specimens of animal origin. J Clin Microbiol 32(2):384–387CrossRefPubMedPubMedCentral Jang SS, Hirsh DC (1994) Characterization, distribution, and microbiological associations of Fusobacterium spp. in clinical specimens of animal origin. J Clin Microbiol 32(2):384–387CrossRefPubMedPubMedCentral
5.
go back to reference Centor RM et al (2015) The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med 162(4):241–247CrossRefPubMed Centor RM et al (2015) The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med 162(4):241–247CrossRefPubMed
6.
go back to reference Brazier JS et al (2002) Fusobacterium necrophorum infections in England and Wales 1990–2000. J Med Microbiol 51(3):269–272CrossRefPubMed Brazier JS et al (2002) Fusobacterium necrophorum infections in England and Wales 1990–2000. J Med Microbiol 51(3):269–272CrossRefPubMed
7.
8.
go back to reference Fujiwara N et al (2020) Involvement of Fusobacterium species in oral Cancer progression: a Literature Review Including other types of Cancer. Int J Mol Sci, 21(17) Fujiwara N et al (2020) Involvement of Fusobacterium species in oral Cancer progression: a Literature Review Including other types of Cancer. Int J Mol Sci, 21(17)
9.
go back to reference Mitsuhashi K et al (2015) Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget 6(9):7209–7220CrossRefPubMedPubMedCentral Mitsuhashi K et al (2015) Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget 6(9):7209–7220CrossRefPubMedPubMedCentral
11.
go back to reference Swidsinski A et al (2011) Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60(1):34–40CrossRefPubMed Swidsinski A et al (2011) Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60(1):34–40CrossRefPubMed
12.
go back to reference Strauss J et al (2011) Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 17(9):1971–1978CrossRefPubMed Strauss J et al (2011) Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 17(9):1971–1978CrossRefPubMed
13.
go back to reference Leal J et al (2010) Development of a novel electronic surveillance system for monitoring of bloodstream infections. Infect Control Hosp Epidemiol 31(7):740–747CrossRefPubMed Leal J et al (2010) Development of a novel electronic surveillance system for monitoring of bloodstream infections. Infect Control Hosp Epidemiol 31(7):740–747CrossRefPubMed
14.
go back to reference Friedman ND et al (2002) Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797CrossRefPubMed Friedman ND et al (2002) Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797CrossRefPubMed
15.
go back to reference Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed
16.
go back to reference Quan H et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43(11):1130–1139CrossRefPubMed Quan H et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43(11):1130–1139CrossRefPubMed
18.
go back to reference Laupland KB et al (2018) Culturing rate and the surveillance of bloodstream infections: a population-based assessment. Clin Microbiol Infect 24(8):910e1–910e4CrossRef Laupland KB et al (2018) Culturing rate and the surveillance of bloodstream infections: a population-based assessment. Clin Microbiol Infect 24(8):910e1–910e4CrossRef
19.
go back to reference Almohaya AM et al (2020) Fusobacterium bloodstream infections: a literature review and hospital-based case series. Anaerobe 62:102165CrossRefPubMed Almohaya AM et al (2020) Fusobacterium bloodstream infections: a literature review and hospital-based case series. Anaerobe 62:102165CrossRefPubMed
22.
23.
go back to reference Vidaurrazaga MM, McKinley GF, Camins BC (2020) Postpartum Fusobacterium gonidiaformans bacteremia. Anaerobe 62:102168CrossRefPubMed Vidaurrazaga MM, McKinley GF, Camins BC (2020) Postpartum Fusobacterium gonidiaformans bacteremia. Anaerobe 62:102168CrossRefPubMed
24.
go back to reference Garcia-Carretero R et al (2017) Clinical features and outcomes of Fusobacterium species infections in a ten-year follow-up. J Crit Care Med (Targu Mures) 3(4):141–147CrossRefPubMed Garcia-Carretero R et al (2017) Clinical features and outcomes of Fusobacterium species infections in a ten-year follow-up. J Crit Care Med (Targu Mures) 3(4):141–147CrossRefPubMed
25.
go back to reference Pett E, Saeed K, Dryden M (2014) Fusobacterium species infections: clinical spectrum and outcomes at a district general hospital. Infection 42(2):363–370CrossRefPubMed Pett E, Saeed K, Dryden M (2014) Fusobacterium species infections: clinical spectrum and outcomes at a district general hospital. Infection 42(2):363–370CrossRefPubMed
26.
go back to reference Yang CC et al (2011) Characteristics and outcomes of Fusobacterium nucleatum bacteremia–a 6-year experience at a tertiary care hospital in northern Taiwan. Diagn Microbiol Infect Dis 70(2):167–174CrossRefPubMed Yang CC et al (2011) Characteristics and outcomes of Fusobacterium nucleatum bacteremia–a 6-year experience at a tertiary care hospital in northern Taiwan. Diagn Microbiol Infect Dis 70(2):167–174CrossRefPubMed
27.
go back to reference Yusuf E, Wybo I, Piérard D (2016) Case series of patients with Fusobacterium nucleatum bacteremia with emphasis on the presence of cancer. Anaerobe 39:1–3CrossRefPubMed Yusuf E, Wybo I, Piérard D (2016) Case series of patients with Fusobacterium nucleatum bacteremia with emphasis on the presence of cancer. Anaerobe 39:1–3CrossRefPubMed
28.
go back to reference Bourgault AM et al (1997) Fusobacterium bacteremia: clinical experience with 40 cases. Clin Infect Dis 25(Suppl 2):S181–S183CrossRefPubMed Bourgault AM et al (1997) Fusobacterium bacteremia: clinical experience with 40 cases. Clin Infect Dis 25(Suppl 2):S181–S183CrossRefPubMed
30.
go back to reference Su CP et al (2009) Fusobacterium bacteremia: clinical significance and outcomes. J Microbiol Immunol Infect 42(4):336–342PubMed Su CP et al (2009) Fusobacterium bacteremia: clinical significance and outcomes. J Microbiol Immunol Infect 42(4):336–342PubMed
31.
go back to reference Candoni A et al (2003) Fusobacterium nucleatum: a rare cause of bacteremia in neutropenic patients with leukemia and lymphoma. Clin Microbiol Infect 9(11):1112–1115CrossRefPubMed Candoni A et al (2003) Fusobacterium nucleatum: a rare cause of bacteremia in neutropenic patients with leukemia and lymphoma. Clin Microbiol Infect 9(11):1112–1115CrossRefPubMed
32.
go back to reference Fanourgiakis P et al (2003) Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases. Support Care Cancer 11(5):332–335CrossRefPubMed Fanourgiakis P et al (2003) Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases. Support Care Cancer 11(5):332–335CrossRefPubMed
33.
go back to reference Seibel J et al (2020) Fusobacterium nucleatum bacteremia with pneumopathy in a patient receiving eculizumab: a case report. Anaerobe 61:102099CrossRefPubMed Seibel J et al (2020) Fusobacterium nucleatum bacteremia with pneumopathy in a patient receiving eculizumab: a case report. Anaerobe 61:102099CrossRefPubMed
35.
go back to reference Aldridge KE et al (2001) Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob Agents Chemother 45(4):1238–1243CrossRefPubMedPubMedCentral Aldridge KE et al (2001) Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob Agents Chemother 45(4):1238–1243CrossRefPubMedPubMedCentral
36.
go back to reference Könönen E et al (1999) beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. Antimicrob Agents Chemother 43(5):1270–1273CrossRefPubMedPubMedCentral Könönen E et al (1999) beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. Antimicrob Agents Chemother 43(5):1270–1273CrossRefPubMedPubMedCentral
37.
go back to reference Nyfors S et al (2003) Emergence of penicillin resistance among Fusobacterium nucleatum populations of commensal oral flora during early childhood. J Antimicrob Chemother 51(1):107–112CrossRefPubMed Nyfors S et al (2003) Emergence of penicillin resistance among Fusobacterium nucleatum populations of commensal oral flora during early childhood. J Antimicrob Chemother 51(1):107–112CrossRefPubMed
Metadata
Title
Risk of mortality in Fusobacterium species bloodstream infection from a large Australian cohort
Authors
Adam G. Stewart
Felicity Edwards
Patrick N. A. Harris
David L. Paterson
Kevin B. Laupland
Publication date
18-12-2024
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2025
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-024-05012-5

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video